STYLACASE LIMITED

Company Registration Number:
15081734 (England and Wales)

Unaudited statutory accounts for the year ended 31 August 2024

Period of accounts

Start date: 18 August 2023

End date: 31 August 2024

STYLACASE LIMITED

Contents of the Financial Statements

for the Period Ended 31 August 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

STYLACASE LIMITED

Company Information

for the Period Ended 31 August 2024




Director: Kai Douglas Storr
Registered office: 27
Old Gloucester Street
London
England
WC1N 3AX
Company Registration Number: 15081734 (England and Wales)

STYLACASE LIMITED

Directors' Report Period Ended 31 August 2024

The directors present their report with the financial statements of the company for the period ended 31 August 2024

Principal Activities

online sales of mobile phone cases and tech accessories

Political and charitable donations

none

Company policy on the employment of disabled persons

none

Additional information

none

Directors

The director(s) shown below were appointed to the company during the period
Kai Douglas Storr
18 August 2023

This report was approved by the board of directors on 9 October 2024
And Signed On Behalf Of The Board By:

Name: Kai Douglas Storr
Status: Director

STYLACASE LIMITED

Profit and Loss Account

for the Period Ended 31 August 2024


Notes

2024
£
Turnover 9,230
Cost of sales ( 3,228 )
Gross Profit or (Loss) 6,002
Income from coronavirus (COVID-19) business support grants 0
Distribution Costs ( 0 )
Administrative Expenses ( 8,508 )
Other operating income 167
Operating Profit or (Loss) ( 2,339 )
Interest Receivable and Similar Income 0
Interest Payable and Similar Charges ( 0 )
Profit or (Loss) Before Tax ( 2,339 )
Tax on Profit ( 0 )
Profit or (Loss) for Period ( 2,339 )

The notes form part of these financial statements

STYLACASE LIMITED

Balance sheet

As at 31 August 2024


Notes

2024
£
Fixed assets
Intangible assets: 4 0
Tangible assets: 5 0
Total fixed assets: 0
Current assets
Stocks: 0
Debtors: 6 0
Cash at bank and in hand: 0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: 7 ( 0 )
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Creditors: amounts falling due after more than one year: 8 ( 0 )
Provision for liabilities: ( 0 )
Accruals and deferred income: ( 2,338 )
Total net assets (liabilities): ( 2,338 )

The notes form part of these financial statements

STYLACASE LIMITED

Balance sheet continued

As at 31 August 2024


Notes

2024
£
Capital and reserves
Called up share capital: 1
Revaluation reserve: 9 0
Profit and loss account: ( 2,339 )
Shareholders funds: ( 2,338 )

For the year ending 31 August 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 9 October 2024
And Signed On Behalf Of The Board By:

Name: Kai Douglas Storr
Status: Director

The notes form part of these financial statements

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 2. Employees


    2024
    Average number of employees during the period 0

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

  • 3. Off balance sheet disclosure

    No

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

4. Intangible assets

Goodwill Other Total
Cost £ £ £
Additions - - -
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 August 2024 - - -
Amortisation
Charge for year - - -
On disposals - - -
Other adjustments - - -
Amortisation at 31 August 2024 - - -
Net book value
Net book value at 31 August 2024 - - -

no intangible or tangible assets were held

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

5. Tangible assets

Office equipment Total
Cost £ £
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 August 2024 - -
Depreciation
Charge for year - -
On disposals - -
Other adjustments - -
At 31 August 2024 - -
Net book value
At 31 August 2024 - -

no tangible assets were held

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

6. Debtors


2024
£
Trade debtors 0
Prepayments and accrued income 0
Other debtors 0
Total 0
Debtors due after more than one year: 0

no money is owed to the company or creditors

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

7.Creditors: amounts falling due within one year note


2024
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Trade creditors 0
Taxation and social security 0
Accruals and deferred income 0
Other creditors 0
Total 0

no loans were made, nop money is owed, no money was made outside of the business activites

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

8.Creditors: amounts falling due after more than one year


2024
£
Bank loans and overdrafts 0
Amounts due under finance leases and hire purchase contracts 0
Other creditors 0
Total 0

no money is owed to the company

STYLACASE LIMITED

Notes to the Financial Statements

for the Period Ended 31 August 2024

9. Revaluation reserve


2024
£
Surplus or deficit after revaluation 0
Balance at 31 August 2024 0